New York, 12/3/2015 – Following months of anticipation among healthcare innovators and a final round of competition, the HITLAB (Healthcare Innovation Technology) World Cup Grand Prize Winner has been crowned: Ceeable, developer of the Ceeable Visual Field Analyzer (CVFA), was awarded $10,000 and the distinction “Best Health Tech Innovation of 2015.”

CVFA is a visual field test that can detect, classify, and monitor degenerative eye disease using only a tablet.

New Governance is working with Ceeable to develop and commercialize the Ceeable Visual Field Analyzer (CVFA), CVFA is a revolutionary web-based software tool that detects and monitors retinopathies using only a touch screen device (such as an iPad®).

In May 2015, the US Patent & Trademark Office formally renewed the primary US Patent for New Governance's TrackGauge system, instrument, and design (7,900,368). This extends New Governance’s formal IP rights in both the US and amongst PCT members. The company also maintains an additional US Patent on the TrackGauge system, instrument, and design (8,069,579).

About TrackGauge:
The top-end speed and safety of modern high-speed rail trains is determined in part by the alignment and accuracy of the rails. TrackGauge is a durable, hand-held electronic measurement instrument that can be deployed by rail maintenance crews to accurately monitor and maintain high-speed rail lines in a wide variety of weather conditions. The TrackGauge system, instrumentation and design developed by New Governance are currently deployed and used throughout Asia.

The US Army recommended the expanded use of PHIMT, a customized version of New Governance’s HPA software, as the primary tracking and reporting repository for health information disclosures that occur under patient authorization.

Since 2004, HPA has been used by the Military Health System as the repository for health information disclosures and compliance activities associated with HIPAA Privacy.

Now HPA will be used in an expanded role at Army healthcare facilities to track the uses and disclosures of patient health information that occur under a patient's authorization. This new PHIMT functionality will provide an efficient electronic replacement to existing procedures which are primarily manual.

Blue Cross Blue Shield of Tennessee formally renewed its HPA license, support and maintenance option with New Governance. Under the terms of the agreement, New Governance will provide support and maintenance for HPA in all BCBST facilities throughout 2015.

New Governance announced that it would partner with Ceeable, Inc. the California Institute of Technology, and the Center for Military Medicine Research to commercialize Ceeable Visual Field Analyzer (CVFA), a revolutionary web-based software tool that detects and monitors retinopathies using only a touch screen device (such as an iPad®).

In multiple clinical studies since 2000, conditions such as glaucoma, age-related macular degeneration (AMD), anterior ischemic optic neuropathy, optic neuritis, ocular hypertension, macular edema, and ethambutol toxicity have been successfully detected by CVFA. Since the CVFA technology only requires a generic touch screen device, it stands to revolutionize the way retinopathies are detected and treated for billions of people worldwide.

Under the terms of the teaming agreement New Governance will work directly with Dr. Wolfgang Fink (the co-inventor of 3D-CTAG, the base technology in CVFA) and his colleagues at Caltech, the University of Arizona, and the Center for Military Medicine Research to move CVFA beyond the lab and into a fully commercialized product.

Dr Fink is the founder of the Visual and Autonomous Exploration Systems Research Laboratory at Caltech. He is also an associate Professor and the inaugural Edward & Maria Keonjian Endowed Chair in Microelectronics at the University of Arizona in Tucson, Arizona in the Departments of Electrical & Computer Engineering, Biomedical Engineering, Systems & Industrial Engineering, and Ophthalmology & Vision Science.